This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Drug Infusion Systems are used in wide ranges of pharmacological therapies to administer drugs like antibiotics, chemotherapy drugs, insulin, painkillers, intravenously or through non-oral routes, such as intramuscular injections and epidural routes in a controlled manner.
MARKET DYNAMICS
The Drug Infusion Systems market is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of chronic disease like cardiovascular disease, strokes, cancer, type 2 diabetes etc., growing geriatric population, technological advancements, rising healthcare expenditure, its portability and easy to use feature and visual monitoring features. Nevertheless, high cost of drug infusion system, dearth of skilled professional and strict government regulatory is expected to restrain the growth of the market during the forecast period.
MARKET SCOPE
The "Global Drug Infusion Systems Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of Drug Infusion Systems market with detailed market segmentation by product type, mode of administration, application, end-user and geography. The global Drug Infusion Systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Drug Infusion Systems market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Drug Infusion Systems market is segmented on the basis of Product, Mode of Administration, Application, and End-User. Based on Product the market is segmented into Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia Pump, Insulin Pump, Implantable Infusion System. Based on Application the market is segmented into Oncology, Diabetes, Analgesia, Nutrition, Hematology, Pediatric, Others. Based on Mode of Administration the market is segmented into Intravenous, Subcutaneous, Arterial, Epidural, Others. Based on End User the market is segmented into Hospitals, Ambulatory Surgical Centers, Others.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Drug Infusion Systems market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drug Infusion Systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region. The report analyzes factors affecting Drug Infusion Systems market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drug Infusion Systems market in these regions.
Get more information on this report :
MARKET PLAYERS
The reports cover key developments in the Drug Infusion Systems Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Drug Infusion Systems Market are anticipated to lucrative growth opportunities in the future with the rising demand for Drug Infusion Systems in the global market. Below mentioned is the list of few companies engaged in the Drug Infusion Systems market. The report also includes the profiles of key Drug Infusion Systems Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Medtronic
B. Braun Melsungen AG
Baxter
Arcomed AG
Halyard Health, INC
ICU Medical Inc
Insulet Corporation
Terumo Corporation
Smiths Group Plc
Tandem Diabetes Care
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Drug Infusion Systems Market - By Product 1.3.2 Drug Infusion Systems Market - By Mode of Administration 1.3.3 Drug Infusion Systems Market - By Application 1.3.4 Drug Infusion Systems Market - By End-User 1.3.5 Drug Infusion Systems Market - By Region 1.3.5.1 By Country 2. KEY TAKEAWAYS 3. RESEARCH METHODOLOGY 4. DRUG INFUSION SYSTEMS MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS 5. DRUG INFUSION SYSTEMS MARKET - KEY MARKET DYNAMICS 5.1. KEY MARKET DRIVERS 5.2. KEY MARKET RESTRAINTS 5.3. KEY MARKET OPPORTUNITIES 5.4. FUTURE TRENDS 5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC 6. DRUG INFUSION SYSTEMS MARKET - GLOBAL MARKET ANALYSIS 6.1. DRUG INFUSION SYSTEMS - GLOBAL MARKET OVERVIEW 6.2. DRUG INFUSION SYSTEMS - GLOBAL MARKET AND FORECAST TO 2028 6.3. MARKET POSITIONING/MARKET SHARE 7. DRUG INFUSION SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT 7.1. OVERVIEW 7.2. PRODUCT MARKET FORECASTS AND ANALYSIS 7.3. ELASTOMERIC INFUSION SYSTEM 7.3.1. Overview 7.3.2. Elastomeric Infusion System Market Forecast and Analysis 7.4. DISPOSABLE INFUSION SYSTEM 7.4.1. Overview 7.4.2. Disposable Infusion System Market Forecast and Analysis 7.5. SYRINGE INFUSION SYSTEM 7.5.1. Overview 7.5.2. Syringe Infusion System Market Forecast and Analysis 7.6. PERISTALTIC PUMP 7.6.1. Overview 7.6.2. Peristaltic Pump Market Forecast and Analysis 7.7. MULTI-CHANNEL PUMP 7.7.1. Overview 7.7.2. Multi-Channel Pump Market Forecast and Analysis 7.8. PATIENT-CONTROLLED ANALGESIA PUMP 7.8.1. Overview 7.8.2. Patient-Controlled Analgesia Pump Market Forecast and Analysis 7.9. INSULIN PUMP 7.9.1. Overview 7.9.2. Insulin Pump Market Forecast and Analysis 7.10. IMPLANTABLE INFUSION SYSTEM 7.10.1. Overview 7.10.2. Implantable Infusion System Market Forecast and Analysis 8. DRUG INFUSION SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - MODE OF ADMINISTRATION 8.1. OVERVIEW 8.2. MODE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS 8.3. ONCOLOGY 8.3.1. Overview 8.3.2. Oncology Market Forecast and Analysis 8.4. DIABETES 8.4.1. Overview 8.4.2. Diabetes Market Forecast and Analysis 8.5. ANALGESIA 8.5.1. Overview 8.5.2. Analgesia Market Forecast and Analysis 8.6. NUTRITION 8.6.1. Overview 8.6.2. Nutrition Market Forecast and Analysis 8.7. HEMATOLOGY 8.7.1. Overview 8.7.2. Hematology Market Forecast and Analysis 8.8. PEDIATRIC 8.8.1. Overview 8.8.2. Pediatric Market Forecast and Analysis 8.9. OTHERS 8.9.1. Overview 8.9.2. Others Market Forecast and Analysis 9. DRUG INFUSION SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION 9.1. OVERVIEW 9.2. APPLICATION MARKET FORECASTS AND ANALYSIS 9.3. INTRAVENOUS 9.3.1. Overview 9.3.2. Intravenous Market Forecast and Analysis 9.4. SUBCUTANEOUS 9.4.1. Overview 9.4.2. Subcutaneous Market Forecast and Analysis 9.5. ARTERIAL 9.5.1. Overview 9.5.2. Arterial Market Forecast and Analysis 9.6. EPIDURAL 9.6.1. Overview 9.6.2. Epidural Market Forecast and Analysis 9.7. OTHERS 9.7.1. Overview 9.7.2. Others Market Forecast and Analysis 10. DRUG INFUSION SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - END-USER 10.1. OVERVIEW 10.2. END-USER MARKET FORECASTS AND ANALYSIS 10.3. HOSPITALS 10.3.1. Overview 10.3.2. Hospitals Market Forecast and Analysis 10.4. AMBULATORY SURGICAL CENTERS 10.4.1. Overview 10.4.2. Ambulatory Surgical Centers Market Forecast and Analysis 10.5. OTHERS. 10.5.1. Overview 10.5.2. Others. Market Forecast and Analysis 11. DRUG INFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS 11.1. NORTH AMERICA 11.1.1 North America Drug Infusion Systems Market Overview 11.1.2 North America Drug Infusion Systems Market Forecasts and Analysis 11.1.3 North America Drug Infusion Systems Market Forecasts and Analysis - By Product 11.1.4 North America Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration 11.1.5 North America Drug Infusion Systems Market Forecasts and Analysis - By Application 11.1.6 North America Drug Infusion Systems Market Forecasts and Analysis - By End-User 11.1.7 North America Drug Infusion Systems Market Forecasts and Analysis - By Countries 11.1.7.1 United States Drug Infusion Systems Market 11.1.7.1.1 United States Drug Infusion Systems Market by Product 11.1.7.1.2 United States Drug Infusion Systems Market by Mode of Administration 11.1.7.1.3 United States Drug Infusion Systems Market by Application 11.1.7.1.4 United States Drug Infusion Systems Market by End-User 11.1.7.2 Canada Drug Infusion Systems Market 11.1.7.2.1 Canada Drug Infusion Systems Market by Product 11.1.7.2.2 Canada Drug Infusion Systems Market by Mode of Administration 11.1.7.2.3 Canada Drug Infusion Systems Market by Application 11.1.7.2.4 Canada Drug Infusion Systems Market by End-User 11.1.7.3 Mexico Drug Infusion Systems Market 11.1.7.3.1 Mexico Drug Infusion Systems Market by Product 11.1.7.3.2 Mexico Drug Infusion Systems Market by Mode of Administration 11.1.7.3.3 Mexico Drug Infusion Systems Market by Application 11.1.7.3.4 Mexico Drug Infusion Systems Market by End-User 11.1.7.4 US Drug Infusion Systems Market 11.1.7.4.1 US Drug Infusion Systems Market by Product 11.1.7.4.2 US Drug Infusion Systems Market by Mode of Administration 11.1.7.4.3 US Drug Infusion Systems Market by Application 11.1.7.4.4 US Drug Infusion Systems Market by End-User 11.2. EUROPE 11.2.1 Europe Drug Infusion Systems Market Overview 11.2.2 Europe Drug Infusion Systems Market Forecasts and Analysis 11.2.3 Europe Drug Infusion Systems Market Forecasts and Analysis - By Product 11.2.4 Europe Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration 11.2.5 Europe Drug Infusion Systems Market Forecasts and Analysis - By Application 11.2.6 Europe Drug Infusion Systems Market Forecasts and Analysis - By End-User 11.2.7 Europe Drug Infusion Systems Market Forecasts and Analysis - By Countries 11.2.7.1 Germany Drug Infusion Systems Market 11.2.7.1.1 Germany Drug Infusion Systems Market by Product 11.2.7.1.2 Germany Drug Infusion Systems Market by Mode of Administration 11.2.7.1.3 Germany Drug Infusion Systems Market by Application 11.2.7.1.4 Germany Drug Infusion Systems Market by End-User 11.2.7.2 France Drug Infusion Systems Market 11.2.7.2.1 France Drug Infusion Systems Market by Product 11.2.7.2.2 France Drug Infusion Systems Market by Mode of Administration 11.2.7.2.3 France Drug Infusion Systems Market by Application 11.2.7.2.4 France Drug Infusion Systems Market by End-User 11.2.7.3 Italy Drug Infusion Systems Market 11.2.7.3.1 Italy Drug Infusion Systems Market by Product 11.2.7.3.2 Italy Drug Infusion Systems Market by Mode of Administration 11.2.7.3.3 Italy Drug Infusion Systems Market by Application 11.2.7.3.4 Italy Drug Infusion Systems Market by End-User 11.2.7.4 Spain Drug Infusion Systems Market 11.2.7.4.1 Spain Drug Infusion Systems Market by Product 11.2.7.4.2 Spain Drug Infusion Systems Market by Mode of Administration 11.2.7.4.3 Spain Drug Infusion Systems Market by Application 11.2.7.4.4 Spain Drug Infusion Systems Market by End-User 11.2.7.5 United Kingdom Drug Infusion Systems Market 11.2.7.5.1 United Kingdom Drug Infusion Systems Market by Product 11.2.7.5.2 United Kingdom Drug Infusion Systems Market by Mode of Administration 11.2.7.5.3 United Kingdom Drug Infusion Systems Market by Application 11.2.7.5.4 United Kingdom Drug Infusion Systems Market by End-User 11.3. ASIA-PACIFIC 11.3.1 Asia-Pacific Drug Infusion Systems Market Overview 11.3.2 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis 11.3.3 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By Product 11.3.4 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration 11.3.5 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By Application 11.3.6 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By End-User 11.3.7 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By Countries 11.3.7.1 Australia Drug Infusion Systems Market 11.3.7.1.1 Australia Drug Infusion Systems Market by Product 11.3.7.1.2 Australia Drug Infusion Systems Market by Mode of Administration 11.3.7.1.3 Australia Drug Infusion Systems Market by Application 11.3.7.1.4 Australia Drug Infusion Systems Market by End-User 11.3.7.2 China Drug Infusion Systems Market 11.3.7.2.1 China Drug Infusion Systems Market by Product 11.3.7.2.2 China Drug Infusion Systems Market by Mode of Administration 11.3.7.2.3 China Drug Infusion Systems Market by Application 11.3.7.2.4 China Drug Infusion Systems Market by End-User 11.3.7.3 India Drug Infusion Systems Market 11.3.7.3.1 India Drug Infusion Systems Market by Product 11.3.7.3.2 India Drug Infusion Systems Market by Mode of Administration 11.3.7.3.3 India Drug Infusion Systems Market by Application 11.3.7.3.4 India Drug Infusion Systems Market by End-User 11.3.7.4 Japan Drug Infusion Systems Market 11.3.7.4.1 Japan Drug Infusion Systems Market by Product 11.3.7.4.2 Japan Drug Infusion Systems Market by Mode of Administration 11.3.7.4.3 Japan Drug Infusion Systems Market by Application 11.3.7.4.4 Japan Drug Infusion Systems Market by End-User 11.4. MIDDLE EAST AND AFRICA 11.4.1 Middle East and Africa Drug Infusion Systems Market Overview 11.4.2 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis 11.4.3 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By Product 11.4.4 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration 11.4.5 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By Application 11.4.6 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By End-User 11.4.7 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By Countries 11.4.7.1 South Africa Drug Infusion Systems Market 11.4.7.1.1 South Africa Drug Infusion Systems Market by Product 11.4.7.1.2 South Africa Drug Infusion Systems Market by Mode of Administration 11.4.7.1.3 South Africa Drug Infusion Systems Market by Application 11.4.7.1.4 South Africa Drug Infusion Systems Market by End-User 11.4.7.2 Saudi Arabia Drug Infusion Systems Market 11.4.7.2.1 Saudi Arabia Drug Infusion Systems Market by Product 11.4.7.2.2 Saudi Arabia Drug Infusion Systems Market by Mode of Administration 11.4.7.2.3 Saudi Arabia Drug Infusion Systems Market by Application 11.4.7.2.4 Saudi Arabia Drug Infusion Systems Market by End-User 11.4.7.3 U.A.E Drug Infusion Systems Market 11.4.7.3.1 U.A.E Drug Infusion Systems Market by Product 11.4.7.3.2 U.A.E Drug Infusion Systems Market by Mode of Administration 11.4.7.3.3 U.A.E Drug Infusion Systems Market by Application 11.4.7.3.4 U.A.E Drug Infusion Systems Market by End-User 11.5. SOUTH AND CENTRAL AMERICA 11.5.1 South and Central America Drug Infusion Systems Market Overview 11.5.2 South and Central America Drug Infusion Systems Market Forecasts and Analysis 11.5.3 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By Product 11.5.4 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration 11.5.5 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By Application 11.5.6 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By End-User 11.5.7 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By Countries 11.5.7.1 Brazil Drug Infusion Systems Market 11.5.7.1.1 Brazil Drug Infusion Systems Market by Product 11.5.7.1.2 Brazil Drug Infusion Systems Market by Mode of Administration 11.5.7.1.3 Brazil Drug Infusion Systems Market by Application 11.5.7.1.4 Brazil Drug Infusion Systems Market by End-User 11.5.7.2 Argentina Drug Infusion Systems Market 11.5.7.2.1 Argentina Drug Infusion Systems Market by Product 11.5.7.2.2 Argentina Drug Infusion Systems Market by Mode of Administration 11.5.7.2.3 Argentina Drug Infusion Systems Market by Application 11.5.7.2.4 Argentina Drug Infusion Systems Market by End-User 12. INDUSTRY LANDSCAPE 12.1. MERGERS AND ACQUISITIONS 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 12.3. NEW PRODUCT LAUNCHES 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS 13. DRUG INFUSION SYSTEMS MARKET, KEY COMPANY PROFILES 13.1. MEDTRONIC 13.1.1. Key Facts 13.1.2. Business Description 13.1.3. Products and Services 13.1.4. Financial Overview 13.1.5. SWOT Analysis 13.1.6. Key Developments 13.2. B. BRAUN MELSUNGEN AG 13.2.1. Key Facts 13.2.2. Business Description 13.2.3. Products and Services 13.2.4. Financial Overview 13.2.5. SWOT Analysis 13.2.6. Key Developments 13.3. BAXTER 13.3.1. Key Facts 13.3.2. Business Description 13.3.3. Products and Services 13.3.4. Financial Overview 13.3.5. SWOT Analysis 13.3.6. Key Developments 13.4. ARCOMED AG 13.4.1. Key Facts 13.4.2. Business Description 13.4.3. Products and Services 13.4.4. Financial Overview 13.4.5. SWOT Analysis 13.4.6. Key Developments 13.5. HALYARD HEALTH, INC 13.5.1. Key Facts 13.5.2. Business Description 13.5.3. Products and Services 13.5.4. Financial Overview 13.5.5. SWOT Analysis 13.5.6. Key Developments 13.6. ICU MEDICAL INC 13.6.1. Key Facts 13.6.2. Business Description 13.6.3. Products and Services 13.6.4. Financial Overview 13.6.5. SWOT Analysis 13.6.6. Key Developments 13.7. INSULET CORPORATION 13.7.1. Key Facts 13.7.2. Business Description 13.7.3. Products and Services 13.7.4. Financial Overview 13.7.5. SWOT Analysis 13.7.6. Key Developments 13.8. TERUMO CORPORATION 13.8.1. Key Facts 13.8.2. Business Description 13.8.3. Products and Services 13.8.4. Financial Overview 13.8.5. SWOT Analysis 13.8.6. Key Developments 13.9. SMITHS GROUP PLC 13.9.1. Key Facts 13.9.2. Business Description 13.9.3. Products and Services 13.9.4. Financial Overview 13.9.5. SWOT Analysis 13.9.6. Key Developments 13.10. TANDEM DIABETES CARE, INC 13.10.1. Key Facts 13.10.2. Business Description 13.10.3. Products and Services 13.10.4. Financial Overview 13.10.5. SWOT Analysis 13.10.6. Key Developments 14. APPENDIX 14.1. ABOUT THE INSIGHT PARTNERS 14.2. GLOSSARY OF TERMS
The List of Companies
- Medtronic - B. Braun Melsungen AG - Baxter - Arcomed AG - Halyard Health, INC - ICU Medical Inc - Insulet Corporation - Terumo Corporation - Smiths Group Plc - Tandem Diabetes Care
